Ana C Garrido-castro, Md

This study is testing whether adding an immunotherapy drug (pembrolizumab) to a targeted cancer drug (sacituzumab govitecan) works better than the targeted drug alone for people with a specific type of advanced breast cancer that has stopped responding to hormone therapy. About 1…